UDP-n-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/(GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
A Standard patent application filed on 24 August 2000 credited to Clausen, Henrik ; Schwientek, Tilo

Details

Application number :

66868  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

UDP-n-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R/(GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3  

Inventor :

Clausen, Henrik ; Schwientek, Tilo  

Agent name :

Freehills Patent & Trade Mark Attorneys  

Address for service :

Level 43 101 Collins Street MELBOURNE VIC 3000  

Filing date :

24 August 2000  

Associated companies :

 

Applicant name :

Glycozym ApS  

Applicant address :

Agern Alle 3, DK-2970 Horsholm Denmark  

Old name :

 

Original Source :

Go  

Same Inventor

• UDP-N- acetyl glucosamine: galactose-beta1, 3-N- acetyl...
• UDP-N-acetylglucosamine: galactose-B1,...